In this enduring activity, 2 experts discuss the evolving science and clinical application of ADCs latest efficacy and safety data, biomarker guidance, and expert insights on where and how HER2- and TROP2-directed ADCs fit into contemporary treatment algorithms. As a result of this educational curriculum, learners should be better able to: 1. Identify the rationale for targeting HER2 and TROP2 in the treatment of NSCLC; 2. Discuss the clinical impact of approved and emerging HER2- and TROP2-directed antibody-drug conjugates (ADCs) in NSCLC; and, 3. Formulate evidence-based strategies for the individualized management of patients with NSCLC using HER2- and TROP2-directed ADCs. Learners can access downloadable materials for future use.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 27 Trinity Place, Suite 185
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- includes Online course / module
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedDec 29, 2025
-
Last day to claim creditDec 29, 2026 3 months left
-
Answers in CME Inc. (AiCME) ADC-elerating Progress: Targeting TROP2 in Triple-Negative Breast Cancer to Improve Front-Line Care
-
Answers in CME Inc. (AiCME) Rapid Roundup 2025 in NSCLC: Keeping Up with ADC Therapies Driving Precision Lung Cancer Care
-
Answers in CME Inc. (AiCME) Navigating ADC Therapy in Lung Cancer: An APP Guide to Selection, Safety, and Care Coordination
